A 32-year-old gravida 2, para 1 woman at 38 weeks gestation is admitted to the labor and delivery unit with strong, regular contractions. During the active phase of labor, she suddenly develops severe dyspnea, chest pain, and becomes cyanotic. Her blood pressure drops to 80/40 mmHg, heart rate increases to 140 bpm, and oxygen saturation falls to 85%. What is the most critical assessment finding that would confirm the nurse's suspicion of anaphylactoid syndrome of pregnancy (ASP)?

ASP is confirmed by coagulopathy with prolonged bleeding times and decreased fibrinogen levels, indicating DIC. Other options (meconium, elevated WBC, abdominal pain) are not specific to ASP.

Understanding Anaphylactoid Syndrome of Pregnancy (ASP)
Anaphylactoid syndrome of pregnancy (ASP), historically and more commonly referred to as amniotic fluid embolism (AFE), is a devastating and unpredictable obstetric emergency. As described in the literature, it is not a simple mechanical blockage of a pulmonary vessel by fetal debris. Instead, it is a complex, severe systemic reaction that mimics anaphylaxis, characterized by a sudden onset of cardiorespiratory collapse and, critically, a profound coagulopathy ^[1]. When amniotic fluid or fetal material enters the maternal circulation, it triggers an abnormal activation of the maternal immune system and complement cascade, leading to the clinical triad of acute hypoxia, cardiovascular collapse, and disseminated intravascular coagulation (DIC).

Analyzing the Clinical Presentation
The patient’s sudden dyspnea, chest pain, cyanosis, hypotension (80/40 mmHg), tachycardia (140 bpm), and hypoxemia (85%) during active labor is the classic initial presentation of ASP/AFE. This phase of cardiorespiratory collapse is the first "hit" in a two-phase process. The second, and equally lethal, phase is the rapid development of a consumptive coagulopathy, which manifests as DIC. The foundational literature defines AFE by this combination of sudden cardiorespiratory collapse and DIC [1,3]. The endothelial injury, specifically the degradation of the endothelial glycocalyx (eGCX), is now understood to be a central mechanism that amplifies this coagulopathy and leads to massive hemorrhage ^[4].

Evaluating the Answer Choices
To confirm a suspicion of ASP, the nurse must look for evidence of this rapidly developing DIC, as the initial cardiorespiratory symptoms are dramatic but not specific to ASP.

- Option 1: Observation of meconium-stained amniotic fluid is a sign of possible fetal distress but is not a diagnostic criterion for ASP in the mother. While fetal distress is often a concurrent finding prompting emergency delivery, it does not confirm the maternal syndrome ^[3].
- Option 2: An elevated white blood cell count suggests an infectious or inflammatory process, such as chorioamnionitis. It is not a hallmark of the immediate, catastrophic immune-mediated coagulopathy seen in ASP.
- Option 3: Sudden severe abdominal pain with a rigid, board-like abdomen is the classic presentation of a placental abruption. While a placental abruption is a major trigger for obstetric DIC ^[4], this specific assessment finding points to the etiology of abruption itself, not the systemic syndrome of ASP. The question asks what confirms the suspicion of ASP, which is a distinct diagnosis.
- Option 4: Coagulopathy with prolonged bleeding time and decreased fibrinogen levels is the most critical confirmatory finding. ASP/AFE rapidly consumes clotting factors, leading to DIC. Laboratory evidence of this, such as a dramatic drop in fibrinogen and a prolonged prothrombin time, confirms that the patient has progressed to the hemorrhagic phase of the syndrome. This is a defining feature of the condition, as AFE is frequently described as a catastrophic event characterized by DIC [1,2,3]. The profound endothelial injury inherent to ASP directly triggers this systemic, life-threatening coagulopathy ^[4].